Most Active Stories
- US 641 South Widening Receives Top Priority on Purchase Area Projects List
- UPDATE: Murray State's Provost Is Stepping Down to Be 'On Loan' to CPE
- Kentucky Primary Election Live Blog: James Comer to Seek a Recanvass
- James Comer’s Quest To ‘Pass A Bold Agenda’ Gets Bumpy
- How Could Kentucky Farmers Use Drones?
Fri February 24, 2012
Stivers Withdraws Pseudoephedrine Bill
A Senate bill that would have made pseudoephedrine available by prescription only has surprisingly been killed by its sponsor.
State Senator Robert Stivers withdrew Senate Bill 50 Thursday, to the objection of several of his colleagues.
Pseudoephedrine, or PSE, is a key ingredient in both over-the-counter cold medicines and meth. The bill was meant to curtail meth production by restricting pseudoephedrine sales. The measure barely made it out of committee earlier this session. And Stivers says he killed the bill so he could look into proposals that have a better chance at passing the Senate.
“We’re looking at potentially different alternatives to what we may do,” he says. “We plan to look at some alternatives very first thing next week.”
Stivers declined to say what those compromises may be. But Senator Jerry Rhoads has sponsored a bill that would cap the amount of PSE individuals could buy in a year. And it would require convicted meth offenders to have a prescription to buy cold medicines that contain PSE.
“If I can do something, maybe not everything that I want. But if I can do something to impede the progress of manufacturing and distribution of meth, I will at least take one bite of the apple this session,” says Stivers.
Stivers believes lobbying done by citizen and healthcare groups against his original measure hurt its chances of passing.